Skip to content

Clinical trials

Phase 1/2 Small Cell Lung Carcinoma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 1/2 Country / region: France Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20141
20152
20161
20171
20191
20201
20231
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Terminated4
Completed3
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Boehringer Ingelheim2
AstraZeneca1
Bayer1
BioNTech SE1
Centre René Gauducheau1
G1 Therapeutics, Inc.1
Ipsen1
Marengo Therapeutics, Inc.1
MediLink Therapeutics (Suzhou) Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma15
Breast Neoplasms4
Carcinoma, Non-Small-Cell Lung4
Stomach Neoplasms3
Colorectal Neoplasms2
Endometrial Neoplasms2
Head and Neck Neoplasms2
Lung Neoplasms2
Melanoma2
Neoplasms2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.